Man Infraconstruction Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 18, 2025, 12:03 pm

Competitors of Man Infraconstruction Ltd

All Competitor Stocks of Man Infraconstruction Ltd

Quarterly Result

Last Updated: August 20, 2025, 7:20 am

Below is a detailed analysis of the quarterly data for Man Infraconstruction Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 183.00 Cr.. The value appears to be declining and may need further review. It has decreased from 294.00 Cr. (Mar 2025) to 183.00 Cr., marking a decrease of 111.00 Cr..
• For Expenses, as of Jun 2025, the value is 142.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 187.00 Cr. (Mar 2025) to 142.00 Cr., marking a decrease of 45.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 41.00 Cr.. The value appears to be declining and may need further review. It has decreased from 106.00 Cr. (Mar 2025) to 41.00 Cr., marking a decrease of 65.00 Cr..
• For OPM %, as of Jun 2025, the value is 22.00%. The value appears to be declining and may need further review. It has decreased from 36.00% (Mar 2025) to 22.00%, marking a decrease of 14.00%.
• For Other Income, as of Jun 2025, the value is 45.00 Cr.. The value appears strong and on an upward trend. It has increased from 37.00 Cr. (Mar 2025) to 45.00 Cr., marking an increase of 8.00 Cr..
• For Interest, as of Jun 2025, the value is 3.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 5.00 Cr. (Mar 2025) to 3.00 Cr., marking a decrease of 2.00 Cr..
• For Depreciation, as of Jun 2025, the value is 2.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 2.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 80.00 Cr.. The value appears to be declining and may need further review. It has decreased from 136.00 Cr. (Mar 2025) to 80.00 Cr., marking a decrease of 56.00 Cr..
• For Tax %, as of Jun 2025, the value is 27.00%. The value appears to be improving (decreasing) as expected. It has decreased from 28.00% (Mar 2025) to 27.00%, marking a decrease of 1.00%.
• For Net Profit, as of Jun 2025, the value is 58.00 Cr.. The value appears to be declining and may need further review. It has decreased from 97.00 Cr. (Mar 2025) to 58.00 Cr., marking a decrease of 39.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 1.44. The value appears to be declining and may need further review. It has decreased from 2.05 (Mar 2025) to 1.44, marking a decrease of 0.61.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: November 15, 2025, 4:55 am

Balance Sheet

Last Updated: June 16, 2025, 11:44 am

Below is a detailed analysis of the balance sheet data for Man Infraconstruction Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 75.00 Cr.. The value appears strong and on an upward trend. It has increased from 74.00 Cr. (Mar 2024) to 75.00 Cr., marking an increase of 1.00 Cr..
• For Reserves, as of Mar 2025, the value is 1,688.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,389.00 Cr. (Mar 2024) to 1,688.00 Cr., marking an increase of 299.00 Cr..
• For Borrowings, as of Mar 2025, the value is 36.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 131.00 Cr. (Mar 2024) to 36.00 Cr., marking a decrease of 95.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 378.00 Cr.. The value appears to be improving (decreasing). It has decreased from 560.00 Cr. (Mar 2024) to 378.00 Cr., marking a decrease of 182.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 2,177.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,154.00 Cr. (Mar 2024) to 2,177.00 Cr., marking an increase of 23.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 49.00 Cr.. The value appears to be declining and may need further review. It has decreased from 53.00 Cr. (Mar 2024) to 49.00 Cr., marking a decrease of 4.00 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Investments, as of Mar 2025, the value is 272.00 Cr.. The value appears to be declining and may need further review. It has decreased from 277.00 Cr. (Mar 2024) to 272.00 Cr., marking a decrease of 5.00 Cr..
• For Other Assets, as of Mar 2025, the value is 1,856.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,824.00 Cr. (Mar 2024) to 1,856.00 Cr., marking an increase of 32.00 Cr..
• For Total Assets, as of Mar 2025, the value is 2,177.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,154.00 Cr. (Mar 2024) to 2,177.00 Cr., marking an increase of 23.00 Cr..

Notably, the Reserves (1,688.00 Cr.) exceed the Borrowings (36.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Man Infraconstruction Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 7.59. This value is within the healthy range. It has decreased from 8.09 (Mar 24) to 7.59, marking a decrease of 0.50.
• For Diluted EPS (Rs.), as of Mar 25, the value is 7.59. This value is within the healthy range. It has decreased from 8.09 (Mar 24) to 7.59, marking a decrease of 0.50.
• For Cash EPS (Rs.), as of Mar 25, the value is 9.19. This value is within the healthy range. It has increased from 7.92 (Mar 24) to 9.19, marking an increase of 1.27.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 46.99. It has increased from 40.85 (Mar 24) to 46.99, marking an increase of 6.14.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 46.99. It has increased from 40.85 (Mar 24) to 46.99, marking an increase of 6.14.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 29.53. It has decreased from 34.03 (Mar 24) to 29.53, marking a decrease of 4.50.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 11.92. This value is within the healthy range. It has increased from 11.40 (Mar 24) to 11.92, marking an increase of 0.52.
• For PBIT / Share (Rs.), as of Mar 25, the value is 11.70. This value is within the healthy range. It has increased from 11.13 (Mar 24) to 11.70, marking an increase of 0.57.
• For PBT / Share (Rs.), as of Mar 25, the value is 11.31. This value is within the healthy range. It has increased from 10.18 (Mar 24) to 11.31, marking an increase of 1.13.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 8.96. This value is within the healthy range. It has increased from 7.65 (Mar 24) to 8.96, marking an increase of 1.31.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 7.53. This value is within the healthy range. It has decreased from 8.09 (Mar 24) to 7.53, marking a decrease of 0.56.
• For PBDIT Margin (%), as of Mar 25, the value is 40.37. This value is within the healthy range. It has increased from 33.49 (Mar 24) to 40.37, marking an increase of 6.88.
• For PBIT Margin (%), as of Mar 25, the value is 39.62. This value exceeds the healthy maximum of 20. It has increased from 32.70 (Mar 24) to 39.62, marking an increase of 6.92.
• For PBT Margin (%), as of Mar 25, the value is 38.29. This value is within the healthy range. It has increased from 29.92 (Mar 24) to 38.29, marking an increase of 8.37.
• For Net Profit Margin (%), as of Mar 25, the value is 30.36. This value exceeds the healthy maximum of 10. It has increased from 22.49 (Mar 24) to 30.36, marking an increase of 7.87.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 25.51. This value exceeds the healthy maximum of 20. It has increased from 23.77 (Mar 24) to 25.51, marking an increase of 1.74.
• For Return on Networth / Equity (%), as of Mar 25, the value is 16.03. This value is within the healthy range. It has decreased from 20.52 (Mar 24) to 16.03, marking a decrease of 4.49.
• For Return on Capital Employeed (%), as of Mar 25, the value is 23.60. This value is within the healthy range. It has decreased from 25.77 (Mar 24) to 23.60, marking a decrease of 2.17.
• For Return On Assets (%), as of Mar 25, the value is 12.98. This value is within the healthy range. It has decreased from 13.94 (Mar 24) to 12.98, marking a decrease of 0.96.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. It has decreased from 0.04 (Mar 24) to 0.00, marking a decrease of 0.04.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.02. This value is within the healthy range. It has decreased from 0.08 (Mar 24) to 0.02, marking a decrease of 0.06.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.51. It has decreased from 0.64 (Mar 24) to 0.51, marking a decrease of 0.13.
• For Current Ratio (X), as of Mar 25, the value is 6.00. This value exceeds the healthy maximum of 3. It has increased from 3.42 (Mar 24) to 6.00, marking an increase of 2.58.
• For Quick Ratio (X), as of Mar 25, the value is 4.33. This value exceeds the healthy maximum of 2. It has increased from 2.51 (Mar 24) to 4.33, marking an increase of 1.82.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 2.14. This value is below the healthy minimum of 4. It has increased from 1.01 (Mar 24) to 2.14, marking an increase of 1.13.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 11.88. This value is below the healthy minimum of 20. It has decreased from 20.02 (Mar 24) to 11.88, marking a decrease of 8.14.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 11.54. This value is below the healthy minimum of 20. It has decreased from 19.37 (Mar 24) to 11.54, marking a decrease of 7.83.
• For Earning Retention Ratio (%), as of Mar 25, the value is 88.12. This value exceeds the healthy maximum of 70. It has increased from 79.98 (Mar 24) to 88.12, marking an increase of 8.14.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 88.46. This value exceeds the healthy maximum of 70. It has increased from 80.63 (Mar 24) to 88.46, marking an increase of 7.83.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 30.34. This value is within the healthy range. It has increased from 12.05 (Mar 24) to 30.34, marking an increase of 18.29.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 23.82. This value is within the healthy range. It has increased from 9.09 (Mar 24) to 23.82, marking an increase of 14.73.
• For Enterprise Value (Cr.), as of Mar 25, the value is 5,277.57. It has decreased from 7,220.21 (Mar 24) to 5,277.57, marking a decrease of 1,942.64.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 4.76. This value exceeds the healthy maximum of 3. It has decreased from 5.71 (Mar 24) to 4.76, marking a decrease of 0.95.
• For EV / EBITDA (X), as of Mar 25, the value is 11.80. This value is within the healthy range. It has decreased from 17.06 (Mar 24) to 11.80, marking a decrease of 5.26.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 5.04. This value exceeds the healthy maximum of 3. It has decreased from 6.00 (Mar 24) to 5.04, marking a decrease of 0.96.
• For Retention Ratios (%), as of Mar 25, the value is 88.11. This value exceeds the healthy maximum of 70. It has increased from 79.97 (Mar 24) to 88.11, marking an increase of 8.14.
• For Price / BV (X), as of Mar 25, the value is 3.17. This value exceeds the healthy maximum of 3. It has decreased from 5.18 (Mar 24) to 3.17, marking a decrease of 2.01.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 5.04. This value exceeds the healthy maximum of 3. It has decreased from 6.00 (Mar 24) to 5.04, marking a decrease of 0.96.
• For EarningsYield, as of Mar 25, the value is 0.05. This value is below the healthy minimum of 5. It has increased from 0.03 (Mar 24) to 0.05, marking an increase of 0.02.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness